The standard case for the fund is to invest in rounds with 3 partakers. Despite the Royalties Fund, startups are often financed by Xeraya Capital, OrbiMed, GE Ventures. The meaningful sponsors for the fund in investment in the same round are OrbiMed, Deerfield Capital Management.
We can highlight the next thriving fund investment areas, such as Medical Device, Biotechnology. Among the various public portfolio startups of the fund, we may underline Acutus Medical Besides, a startup requires to be at the age of 6-10 years to receive the investment from the fund.
The common things for fund are deals in the range of 50 - 100 millions dollars. The top activity for fund was in 2019. The fund is generally included in less than 2 deals every year.
Related Funds
| Fund Name | Location |
| Avic Securities | China, Guangdong, Jiangxi |
| Cairngorm Capital | England, London, United Kingdom |
| Fengyun Investment Management | Beijing, Beijing, China |
| Financiere De La Gommerie | - |
| GRIDS Capital | Brazil, São Paulo, São Paulo |
| Guojia Keji Chengguo Zhuanhua Yindao Jijin | - |
| H&S Ventures | California, Corona Del Mar, United States |
| iNetworks | Pennsylvania, Pittsburgh, United States |
| Jacob Ballas Capital India | Delhi, India, New Delhi |
| Jiyou Touzi | China, Hangzhou, Zhejiang |
| Lordship Ventures | Connecticut, Stratford, United States |
| NAIMI Group | - |
| Ohio Partners | - |
| Planven Entrepreneur Ventures | Switzerland, Zürich, Zurich |
| Pont Mestres & Asociados | - |
| Tianyi Chuangtou | China, Shanghai |
| United Rentals | Connecticut, Stamford, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 